Purification and characterization of a naturally processed hepatitis B virus peptide recognized by CD8+ cytotoxic T lymphocytes.
about
Complete hepatitis B virus genome analysis in HBsAg positive mothers and their infants with fulminant hepatitis BVariability and conservation in hepatitis B virus core proteinInfectious Diseases and Immunity: Special Reference to Major Histocompatibility ComplexA defective interference-like phenomenon of human hepatitis B virus in chronic carriers.Functional characterization of naturally occurring variants of human hepatitis B virus containing the core internal deletion mutation.Efficacy of thymosin alpha-1 and interferon alpha in treatment of chronic viral hepatitis B: a randomized controlled studyStrategy for identifying dendritic cell-processed CD4+ T cell epitopes from the HIV gag p24 protein.Cytotoxic T lymphocyte responses and CTL epitope escape mutation in HBsAg, anti-HBe positive individuals.High frequency of functional anti-YMDD and -mutant cytotoxic T lymphocytes after in vitro expansion correlates with successful response to lamivudine therapy for chronic hepatitis BImmunogenicity of twenty peptides representing epitopes of the hepatitis B core and surface antigens by IFN-γ response in chronic and resolved HBV.Vaccinia peptides eluted from HLA-DR1 isolated from virus-infected cells are recognized by CD4+ T cells from a vaccinated donor.Host ethnicity and virus genotype shape the hepatitis B virus-specific T-cell repertoire.Understanding the immunopathogenesis of chronic hepatitis B virus: an Asian prospective.Discovery of naturally processed and HLA-presented class I peptides from vaccinia virus infection using mass spectrometry for vaccine development.Immunoprevalence and immunodominance of HLA-Cw*0801-restricted T cell response targeting the hepatitis B virus envelope transmembrane region.The mechanism of an immature secretion phenotype of a highly frequent naturally occurring missense mutation at codon 97 of human hepatitis B virus core antigenSubtype-independent immature secretion and subtype-dependent replication deficiency of a highly frequent, naturally occurring mutation of human hepatitis B virus core antigen.Hepatitis B core particles as a universal display model: a structure-function basis for development.High structural side chain specificity required at the second position of immunogenic peptides to obtain stable MHC/peptide complexes.Behavior of a short preS1 epitope on the surface of hepatitis B core particles.Preliminary results of Thymosin-a1 versus interferon-alpha-treatment in patients with HBeAg negative and serum HBV DNA positive chronic hepatitis B.Associations between HLA class I alleles and escape mutations in the hepatitis B virus core gene in New Zealand-resident Tongans.A randomized controlled clinical trial on the treatment of Thymosin a1 versus interferon-alpha in patients with hepatitis B.Mutations in hepatitis B virus core regions correlate with hepatocellular injury in Chinese patients with chronic hepatitis B.
P2860
Q24793897-61A5072A-B7DB-43F8-A18F-6EC38741CD7EQ24815672-90D2DF8B-0EE7-4D07-BE5E-426D7113027DQ27487586-FC810169-700B-4D52-B89F-05F3F0BF597BQ33782081-E9B3F4CC-9BBA-400A-AF54-255DF97166D6Q33782419-B56397D9-145C-48BB-862A-F2B1405DA9B5Q34017814-DED14B5F-B773-471F-943D-5C218F1DA817Q34364276-72770F05-3237-442C-A13A-4EFCD3F50702Q35360487-9A6AFAEA-DDF5-4737-A695-FCBE73F431BDQ35597143-04EBFFB1-B842-4298-BED3-2E454712B01DQ35829691-04839B36-C38E-4B1C-BBFD-78DE65CE7F6CQ36836183-7CD09897-32D4-4FBE-A084-39FFDAB96C29Q36949834-296F2831-5532-4411-BA90-0A88FC5BB280Q37195244-51BD101A-1A53-44A3-8F5D-4E8E5DDEE9A9Q37456000-2B9ABAF0-95AF-47A1-9223-D8B3742C78A9Q37547521-FF625C32-4A82-4824-A443-0F60437A9F41Q39594722-9087D06B-0413-48C5-B398-F00C38039D22Q39597042-87CC9601-CB71-49EA-8127-9582765EE2C7Q40826853-A3E4026B-6C61-4DBA-A40E-6A462033D44AQ41064733-ECF66ED9-A63F-41B9-8CF4-100438EF3C8AQ41632743-6EB83C0D-82E1-4196-9EEA-FBD7A1D7795CQ41915848-874FA650-8BD5-43FB-9FE3-BD346E316E70Q42947291-DFE02E6F-F796-49EA-A1BC-49343D504EF3Q43119055-C71758E0-8E11-4650-96D5-656A4FDFBE19Q43206741-B84652C7-FF0F-4AB4-87B9-BE59E4DAF79F
P2860
Purification and characterization of a naturally processed hepatitis B virus peptide recognized by CD8+ cytotoxic T lymphocytes.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on January 1996
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Purification and characterizat ...... CD8+ cytotoxic T lymphocytes.
@en
Purification and characterizat ...... CD8+ cytotoxic T lymphocytes.
@nl
type
label
Purification and characterizat ...... CD8+ cytotoxic T lymphocytes.
@en
Purification and characterizat ...... CD8+ cytotoxic T lymphocytes.
@nl
prefLabel
Purification and characterizat ...... CD8+ cytotoxic T lymphocytes.
@en
Purification and characterizat ...... CD8+ cytotoxic T lymphocytes.
@nl
P2093
P2860
P356
P1476
Purification and characterizat ...... CD8+ cytotoxic T lymphocytes.
@en
P2093
P2860
P304
P356
10.1172/JCI118450
P407
P50
P577
1996-01-01T00:00:00Z